MX9706424A - Uso de la moxonidina para el tratamiento de la aterosclerosis. - Google Patents
Uso de la moxonidina para el tratamiento de la aterosclerosis.Info
- Publication number
- MX9706424A MX9706424A MX9706424A MX9706424A MX9706424A MX 9706424 A MX9706424 A MX 9706424A MX 9706424 A MX9706424 A MX 9706424A MX 9706424 A MX9706424 A MX 9706424A MX 9706424 A MX9706424 A MX 9706424A
- Authority
- MX
- Mexico
- Prior art keywords
- moxonidine
- atherosclerosis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Liquid Crystal Substances (AREA)
Abstract
Se describe el uso de la moxonidina para el tratamiento de la aterosclerosis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95301295 | 1995-02-28 | ||
EP95301295.2 | 1995-02-28 | ||
PCT/EP1996/000783 WO1996026728A2 (en) | 1995-02-28 | 1996-02-21 | Use of moxonidine for the treatment of atherosclerosis |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706424A true MX9706424A (es) | 1997-11-29 |
MXPA97006424A MXPA97006424A (es) | 1998-07-03 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
EP0812197A2 (en) | 1997-12-17 |
CA2212294A1 (en) | 1996-09-06 |
WO1996026728A2 (en) | 1996-09-06 |
US5977121A (en) | 1999-11-02 |
KR19980702511A (ko) | 1998-07-15 |
JPH11501020A (ja) | 1999-01-26 |
AU4941796A (en) | 1996-09-18 |
WO1996026728A3 (en) | 1996-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA964759B (en) | Antithrombotic petidoyl heterocycles. | |
AU6613896A (en) | Chemical compounds | |
AU7443496A (en) | Treatment of migraine | |
AU5750796A (en) | System for the treatment of insomnia | |
AP9600804A0 (en) | Therapeutic amides. | |
AU6513096A (en) | Treatment of fabrics | |
AU3717395A (en) | Compositions for the treatment of skin disorders | |
AUPM761094A0 (en) | Treatment of hides | |
AU4329396A (en) | Use of 3,4-diphenylchromans | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
NO973366L (no) | Fremgangsmåte for behandling av multippel sklerose | |
HU9502623D0 (en) | Use of substituted alkyl-nitrates for the treatment of pathologically increased intraocular pressure | |
WO1996026728A3 (en) | Use of moxonidine for the treatment of atherosclerosis | |
ZA9610433B (en) | Medical use of proteases. | |
AU6829696A (en) | Treatment of solutions | |
GB9502136D0 (en) | Treatment of waste | |
AUPN221195A0 (en) | Combined waste treatment | |
AU8879691A (en) | Treatment of dispersions | |
MX9603087A (es) | Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas. | |
AU3247995A (en) | Treatment of hides | |
AU7323091A (en) | Treatment of wastewater | |
AUPN309095A0 (en) | Treatment of hides | |
AUPN495995A0 (en) | Treatment of hides | |
AU9359898A (en) | Use of moxonidine for the treatment of depression |